Want to create an interactive transcript for this episode?
Podcast: Future Science Group
Episode: NCTalks at AAN 2017: Michael Pender on a new multiple sclerosis treatment
Description: Whilst at the American Academy of Neurology’s Annual Meeting (Boston, MA, USA, 22–28 April 2017), we sat down with Michael Pender (University of Queensland, Australia), who was presenting promising interim findings from a Phase 1 study investigating a novel treatment for multiple sclerosis (MS) at the meeting.
In this interview, Dr Pender discusses the relationship between MS and the Epstain-Barr virus; a link that has been observed in recent studies, and which forms the basis of this most recent clinical trial. In the Phase I study, researchers removed the T cells from six patients with progressive MS, stimulated the T cells to incr...